Feilong Yang

493 total citations
26 papers, 306 citations indexed

About

Feilong Yang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Feilong Yang has authored 26 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Feilong Yang's work include Renal cell carcinoma treatment (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Epigenetics and DNA Methylation (4 papers). Feilong Yang is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Epigenetics and DNA Methylation (4 papers). Feilong Yang collaborates with scholars based in China, Australia and Sweden. Feilong Yang's co-authors include Liyuan Ge, Zhonghua Xu, Shudong Zhang, Lei Yan, Yimeng Song, Hainan Liu, Lulin Ma, Cheng Liu, Cong Zhang and Nengwang Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Feilong Yang

22 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feilong Yang China 12 175 112 94 68 52 26 306
Haiyue Zhao China 11 221 1.3× 148 1.3× 54 0.6× 88 1.3× 75 1.4× 24 373
Angelika Terbuch Austria 13 149 0.9× 103 0.9× 159 1.7× 120 1.8× 172 3.3× 33 397
Bin Fan China 9 88 0.5× 87 0.8× 103 1.1× 30 0.4× 30 0.6× 18 219
Yiming Zhao China 10 122 0.7× 64 0.6× 72 0.8× 62 0.9× 131 2.5× 19 293
Chunji Chen China 10 188 1.1× 109 1.0× 114 1.2× 38 0.6× 96 1.8× 31 361
Valentina Gallá Italy 12 168 1.0× 133 1.2× 74 0.8× 76 1.1× 152 2.9× 19 351
Iben Lyskjær Denmark 11 146 0.8× 158 1.4× 134 1.4× 24 0.4× 81 1.6× 17 297
Ruping Zhao China 10 121 0.7× 96 0.9× 88 0.9× 27 0.4× 89 1.7× 26 261
Baofu Chen China 11 263 1.5× 219 2.0× 151 1.6× 113 1.7× 76 1.5× 28 441

Countries citing papers authored by Feilong Yang

Since Specialization
Citations

This map shows the geographic impact of Feilong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilong Yang more than expected).

Fields of papers citing papers by Feilong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feilong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilong Yang. The network helps show where Feilong Yang may publish in the future.

Co-authorship network of co-authors of Feilong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Feilong Yang. A scholar is included among the top collaborators of Feilong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feilong Yang. Feilong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Kui, et al.. (2025). MRI imaging characteristics of brainstem and midbrain aqueduct in patients with iNPH. Scientific Reports. 15(1). 94–94.
2.
Lu, Gonggong, Feilong Yang, Jing Li, et al.. (2024). Research progress on the use of the optical coherence tomography system for the diagnosis and treatment of central nervous system tumors. SHILAP Revista de lepidopterología. 11(1). 3–18.
5.
Yang, Feilong, et al.. (2023). Claudin 4 enhances the malignancy of glioma cells via NNAT/Wnt signaling.. PubMed. 13(6). 2530–2539. 4 indexed citations
6.
Tao, Bei, Feilong Yang, Xiaobo Yang, et al.. (2021). Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR‐302a. SHILAP Revista de lepidopterología. 11(9). e424–e424. 36 indexed citations
8.
Wu, Zonglong, et al.. (2021). Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma. Frontiers in Genetics. 12. 650416–650416. 17 indexed citations
9.
Chen, Zhigang, Feilong Yang, Liyuan Ge, et al.. (2021). Outcomes of renal cell carcinoma with associated venous tumor thrombus: experience from a large cohort and short time span in a single center. BMC Cancer. 21(1). 766–766. 23 indexed citations
10.
Zhao, Ming, et al.. (2021). BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability. Journal of Endocrinological Investigation. 44(10). 2165–2174. 9 indexed citations
11.
Yang, Feilong, Liyuan Ge, Yimeng Song, et al.. (2021). Identification of a Two‐m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis. BioMed Research International. 2021(1). 4582082–4582082. 7 indexed citations
12.
Tian, Xiaojun, Hong Peng, Zhuo Liu, et al.. (2021). Urothelial carcinoma of the renal pelvis with renal vein and inferior vena cava tumor thrombus: case series and literature review. Translational Andrology and Urology. 10(7). 2879–2888. 2 indexed citations
13.
Wang, Guoliang, Yi Huang, Feilong Yang, et al.. (2020). High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer. Aging. 12(3). 2030–2048. 18 indexed citations
14.
Hind, Daniel, et al.. (2019). A systematic review of classification systems for pilonidal sinus. Techniques in Coloproctology. 23(5). 435–443. 32 indexed citations
15.
Xu, Jianing, Neil D. Gross, Yuanwei Zang, et al.. (2019). Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma. Molecular Diagnosis & Therapy. 23(3). 407–417. 5 indexed citations
16.
Zhang, Cong, Feilong Yang, Zeyan Li, et al.. (2019). <p>Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway</p>. Cancer Management and Research. Volume 11. 7909–7923. 21 indexed citations
17.
Zhang, Cong, Lei Yan, Zheng Ma, et al.. (2019). Elevated Serum Sialic Acid Levels Predict Prostate Cancer As Well As Bone Metastases. Journal of Cancer. 10(2). 449–457. 21 indexed citations
19.
Wang, Hui, Lijian Gao, Nengwang Yu, et al.. (2018). Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors. BioMed Research International. 2018. 1–8. 5 indexed citations
20.
Liu, Min, Feilong Yang, Jaw‐Yuan Wang, et al.. (2016). Evidence for a role of GPRC6A in prostate cancer metastasis based on case-control and in vitro analyses.. PubMed. 20(11). 2235–48. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026